{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:46:14Z","timestamp":1780487174639,"version":"3.54.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1097\/md.0000000000007664","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T20:09:21Z","timestamp":1501618161000},"page":"e7664","source":"Crossref","is-referenced-by-count":19,"title":["Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injury"],"prefix":"10.1097","volume":"96","author":[{"given":"Agnese","family":"Gugliandolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Caio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lina","family":"Mezzatesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Rifici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Placido","family":"Bramanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Mazzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20210226","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0035-1544208","article-title":"Carbapenemase-producing Enterobacteriaceae","volume":"36","author":"Doi","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"R2-24-20210226","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/21505594.2017.1292196","article-title":"Therapeutic options for carbapenem-resistant Enterobacteriaceae infections","volume":"8","author":"Trecarichi","year":"2017","journal-title":"Virulence"},{"key":"R3-24-20210226","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/mdr.2015.0160","article-title":"Colistin increases the cidal activity of antibiotic combinations against multidrug-resistant klebsiella pneumoniae: an in vitro model comparing multiple combination bactericidal testing at one peak serum concentration and time-kill method","volume":"22","author":"Mezzatesta","year":"2016","journal-title":"Microb Drug Resist"},{"key":"R4-24-20210226","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/jac\/dkw239","article-title":"Spotlight on ceftazidime\/avibactam: a new option for MDR Gram-negative infections","volume":"71","author":"Falcone","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"R5-24-20210226","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clinthera.2016.01.018","article-title":"Ceftazidime-avibactam: a novel cephalosporin\/beta-lactamase inhibitor combination for the treatment of resistant gram-negative organisms","volume":"38","author":"Sharma","year":"2016","journal-title":"Clin Ther"},{"key":"R6-24-20210226","doi-asserted-by":"crossref","first-page":"O633","DOI":"10.1111\/1469-0691.12577","article-title":"In vivo multiclonal transfer of bla (KPC-3) from Klebsiella pneumoniae to Escherichia coli in surgery patients","volume":"20","author":"Gona","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R7-24-20210226","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/AAC.00386-10","article-title":"Emergence of Klebsiella pneumoniae coproducing KPC-2 and 16S rRNA methylase ArmA in Poland","volume":"55","author":"Zacharczuk","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R8-24-20210226","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/mdr.2008.0765","article-title":"Class I integron-borne bla (VIM-1) carbapenemase in a strain of Enterobacter cloacae responsible for a case of fatal pneumonia","volume":"14","author":"Perilli","year":"2008","journal-title":"Microb Drug Resist"},{"key":"R9-24-20210226","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1128\/JCM.41.9.4264-4269.2003","article-title":"Multiple CTX-M-type extended-spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy","volume":"41","author":"Pagani","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R10-24-20210226","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1128\/JCM.43.8.4178-4182.2005","article-title":"Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates","volume":"43","author":"Diancourt","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R11-24-20210226","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/jac\/dkt116","article-title":"Emergence of an extensively drug-resistant ArmA- and KPC-2-producing ST101 Klebsiella pneumoniae clone in Italy","volume":"68","author":"Mezzatesta","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"R12-24-20210226","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/AAC.01355-08","article-title":"Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital","volume":"53","author":"Gootz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-24-20210226","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1517\/14712598.2012.681369","article-title":"Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects","volume":"12","author":"da Silva","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"R14-24-20210226","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/5584_2015_5018","article-title":"Carbapenem-resistant klebsiella pneumoniae: results of a laboratory surveillance program in an Italian General Hospital (August 2014\u2013January 2015): surveillance of carbapenem-resistant Klebsiella pneumoniae","volume":"901","author":"Monari","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"R15-24-20210226","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1574-6976.2011.00268.x","article-title":"Multiresistant gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance","volume":"35","author":"Woodford","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"R16-24-20210226","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3389\/fmicb.2016.00895","article-title":"Global dissemination of carbapenemase-producing klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods","volume":"7","author":"Lee","year":"2016","journal-title":"Front Microbiol"},{"key":"R17-24-20210226","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy","volume":"55","author":"Tumbarello","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R18-24-20210226","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/jac\/dkv086","article-title":"Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study","volume":"70","author":"Tumbarello","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R19-24-20210226","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1128\/AAC.06268-11","article-title":"Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens","volume":"56","author":"Qureshi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-24-20210226","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/AAC.00782-08","article-title":"Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections","volume":"53","author":"Daikos","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-24-20210226","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1128\/AAC.02166-13","article-title":"Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems","volume":"58","author":"Daikos","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R22-24-20210226","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1128\/AAC.03579-14","article-title":"Efficacy of a Ceftazidime-Avibactam combination in a murine model of Septicemia caused by Enterobacteriaceae species producing ampc or extended-spectrum beta-lactamases","volume":"58","author":"Levasseur","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-24-20210226","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1128\/AAC.04218-14","article-title":"In vitro antibacterial activity of the ceftazidime-avibactam combination against enterobacteriaceae, including strains with well-characterized beta-lactamases","volume":"59","author":"Levasseur","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-24-20210226","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1128\/AAC.02841-15","article-title":"Assessment of the in vitro activity of ceftazidime-avibactam against multidrug-resistant klebsiella spp. collected in the INFORM Global Surveillance Study, 2012 to 2014","volume":"60","author":"Hackel","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"R25-24-20210226","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1002\/phar.1840","article-title":"Pharmacokinetics of ceftazidime-avibactam in two patients with KPC-producing klebsiella pneumoniae bacteremia and renal impairment","volume":"36","author":"Veillette","year":"2016","journal-title":"Pharmacotherapy"},{"key":"R26-24-20210226","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1128\/AAC.00655-15","article-title":"Successful treatment of carbapenemase-producing pandrug-resistant klebsiella pneumoniae bacteremia","volume":"59","author":"Camargo","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-24-20210226","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijantimicag.2016.06.002","article-title":"Combination treatment with extended-infusion ceftazidime\/avibactam for a KPC-3-producing Klebsiella pneumoniae bacteraemia in a kidney and pancreas transplant patient","volume":"48","author":"Jacobs","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"R28-24-20210226","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/cid\/ciw491","article-title":"Ceftazidime-avibactam for treatment of carbapenem-resistant enterobacteriaceae bacteremia","volume":"63","author":"Wu","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R29-24-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bjid.2016.09.008","article-title":"Risk factors for mortality in patients with ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae","volume":"21","author":"Tuon","year":"2017","journal-title":"Braz J Infect Dis"},{"key":"R30-24-20210226","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.cmi.2015.07.025","article-title":"Clinical and microbiologic characteristics of adult patients with recurrent bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae.","volume":"21","author":"Lee","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R31-24-20210226","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ijantimicag.2017.01.018","article-title":"Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime\/avibactam: a retrospective study with molecular strain characterisation","volume":"49","author":"Krapp","year":"2017","journal-title":"Int J Antimicrob Agents"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000007664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:56:11Z","timestamp":1620960971000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201708040-00024"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":31,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000007664","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}